Back to search

The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis

Data up to Jan 2025

Published1996
Citations26
References56

Total Citations Per Year

Abstract

References (56)

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

1951 • 319,299 citations

Beyond Cholesterol

1989 • 6,533 citations

The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers

1994 • 4,626 citations

A new method for the direct determination of serum cholesterol.

1953 • 2,530 citations

Vitamin E Consumption and the Risk of Coronary Heart Disease in Men

1993 • 2,363 citations

Vitamin E Consumption and the Risk of Coronary Disease in Women

1993 • 2,158 citations

A simple fluorometric assay for lipoperoxide in blood plasma

1976 • 2,101 citations

Continuous Monitoring ofin VztroOxidation of Human Low Density Lipoprotein

1989 • 1,824 citations

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1992 • 1,332 citations

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

1987 • 1,152 citations

A colorimetric method for estimating serum triglycerides

1968 • 1,137 citations

The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion

1995 • 1,123 citations

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

1987 • 1,051 citations

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

1981 • 1,037 citations

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

1987 • 885 citations

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

1990 • 871 citations

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

1990 • 836 citations

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

1992 • 588 citations

Lipoprotein oxidation and lipoprotein-induced cytotoxicity.

1983 • 545 citations

Regulation of the activity of the low density lipoprotein receptor in human fibroblasts

1975 • 477 citations

High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors.

1992 • 471 citations

Enhanced macrophage degradation of biologically modified low density lipoprotein.

1983 • 469 citations

Lipoprotein fractionation.

1973 • 420 citations

HDL, its enzymes and its potential to influence lipid peroxidation

1995 • 416 citations

Labelling of plasma proteins with radioactive iodine

1956 • 379 citations

Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking.

1992 • 354 citations

Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

1990 • 335 citations

α-tocopherol consumption during low-density-lipoprotein oxidation

1990 • 312 citations

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

1994 • 251 citations

Effects of probucol on xanthomata regression in familial hypercholesterolemia

1986 • 232 citations

Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.

1991 • 228 citations

β-Carotene inhibits the oxidative modification of low-density lipoprotein

1991 • 227 citations

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

1994 • 224 citations

Platelet activation by oxidatively modified low density lipoproteins

1989 • 183 citations

Biologically modified LDL increases the adhesive properties of endothelial cells

1991 • 179 citations

Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells.

1992 • 169 citations

Probucol

1989 • 161 citations

Vitamin E content and low density lipoprotein oxidizability induced by free radicals

1990 • 137 citations

Effects of probucol on homozygous cases of familial hypercholesterolemia

1983 • 113 citations

Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells.

1991 • 110 citations

Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease

1993 • 109 citations

Oxidative status of lipoproteins in coronary disease patients

1992 • 102 citations

Supplementation with Vitamin E but Not Beta-Carotene in Vivo Protects Low Density Lipoprotein from Lipid Peroxidation in Vitro

1992 • 99 citations

The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits

1991 • 93 citations

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.

1992 • 87 citations

Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia

1995 • 81 citations

Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro

1990 • 62 citations

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report

1988 • 61 citations

Simultaneous measurement of serum probucol and lipid-soluble antioxidants.

1992 • 55 citations

Probucol Treatment Decreases Serum Concentrations of Diet-Derived Antioxidants

1995 • 53 citations

Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand White rabbits

1992 • 45 citations

Recirculation of cationized ferritin in cultured mouse peritoneal macrophages. Electron microscopic and cytochemical studies with double-labeling technique.

1980 • 31 citations

Changes in atheroma volume estimated from digitized femoral arteriograms

1990 • 22 citations

Influence of lipoprotein lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein

1994 • 9 citations

Changes in atheroma volume estimated from digitized femoral arteriograms

1990 • 8 citations

Repeat femoral arteriography in hyperlipidemic patients

1988 • 2 citations

Cited By (0)

Loading...